1. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease
- Author
-
Seiji Yano, Yasukazu Ohmoto, Saburo Sone, Takashi Haku, and Hiroaki Yanagawa
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,medicine.drug_class ,Pleural effusion ,Sialoglycoproteins ,medicine.medical_treatment ,Immunoenzyme Techniques ,Pleural disease ,Macrophages, Alveolar ,Humans ,Medicine ,Aged ,Aged, 80 and over ,business.industry ,Respiratory disease ,Interleukin ,Pneumonia ,Middle Aged ,respiratory system ,Pleural cavity ,Receptor antagonist ,medicine.disease ,Pleural Effusion, Malignant ,respiratory tract diseases ,Pleural Effusion ,Interleukin 1 Receptor Antagonist Protein ,Cytokine ,medicine.anatomical_structure ,Interleukin 1 receptor antagonist ,Female ,business ,Interleukin-1 - Abstract
Interleukin (IL)-1 is a key cytokine in inflammatory reactions. To clarify the mechanism of inflammation in the pleural cavity, we investigated the contribution of IL-1 and its antagonism to inflammatory processes in the pleural cavity. Interleukin-1 receptor antagonist (IL-1Ra) levels as well as IL-1 beta and interferon-gamma (IFN-gamma) levels were measured by enzyme immunoassay in pleural effusions from 70 patients. Pleural macrophages were also examined as possible sources of these cytokines in 10 patients. IL-1Ra was detectable in 28 patients (40%) out of 70 patients with pleural effusions. Patients with tuberculosis had significantly higher IL-1Ra as well as IFN-gamma levels in pleural effusion than patients with lung cancer. Transudative pleural effusions had low or undetectable IL-IRa levels. On the other hand, IL-1 beta levels were low, except in cases of parapneumonic pleural effusion. Spontaneous production of IL-1Ra pleural macrophages was observed in six patients, and IL-4 significantly augmented its production. Although spontaneous production of IL-1 beta was observed in only two patients, pleural macrophages produced significant amounts of IL-1 beta in response to lipopolysaccharide in all 10 patients examined. These results suggest that interleukin-1 receptor antagonist regulates various reactions by interleukin-1 in pleural effusion, and that pleural macrophages may act in situ as a source of interleukin-1 receptor antagonist.
- Published
- 1996
- Full Text
- View/download PDF